Baxter International Inc. (BAX)
| Market Cap | 12.60B |
| Revenue (ttm) | 10.89B |
| Net Income (ttm) | -155.00M |
| Shares Out | 513.62M |
| EPS (ttm) | -0.31 |
| PE Ratio | n/a |
| Forward PE | 9.77 |
| Dividend | $0.68 (2.77%) |
| Ex-Dividend Date | Aug 29, 2025 |
| Volume | 6,487,970 |
| Open | 24.10 |
| Previous Close | 23.85 |
| Day's Range | 23.88 - 24.61 |
| 52-Week Range | 21.33 - 40.49 |
| Beta | 0.59 |
| Analysts | Hold |
| Price Target | 32.00 (+30.4%) |
| Earnings Date | Jul 31, 2025 |
About BAX
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technolog... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for BAX stock is "Hold." The 12-month stock price target is $32.0, which is an increase of 30.40% from the latest price.
News
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo...
President Trump demands drugmakers slash prices within 60 days
CNBC's Joe Kernen reports on the latest news.
Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook
Q2 adjusted EPS was $0.59, matching guidance but slightly below the $0.61 Street estimate. FY25 EPS forecast lowered to $2.42–$2.52 vs. prior range of $2.47–$2.55.
Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair &...
Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit
Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing fa...
Baxter Reports Second-Quarter 2025 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025. “For the second quarter of 2025, Baxter delivere...
Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter
IRVING, Texas--(BUSINESS WIRE)--Vizient announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter.
Baxter the Brave Mouse Unites Baxterville Against the Cat Pack
Baxter, a brave mouse from Baxterville, faces the Cat Pack's mischief in a heartwarming tale of friendship and forgiveness from Palmetto Publishing. Baxter, a brave mouse from Baxterville, faces the C...
Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, ...
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o...
Medical Equipment Maker Baxter International Names New CEO
Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new CEO.
Baxter International Names Andrew Hider as CEO
Baxter International said on Monday that Andrew Hider will take over as the medical device maker's new Chief Executive Officer.
Baxter Appoints Andrew Hider Chief Executive Officer
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a m...
Baxter Publishes Annual Corporate Responsibility Report, Demonstrating Ongoing Action to Make a Meaningful Difference Around the World
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2024 Corporate Responsibility Report. The annual report demonstrates Baxter's commi...
Mountain Heating and Cooling Transforms Historic Baxter Hotel with Innovative Mitsubishi Heat Pump Installation
Bozeman, June 11, 2025 (GLOBE NEWSWIRE) -- Bozeman, Montana - Mountain Heating and Cooling recently shared details about their Mitsubishi Heat Pump Installation at the Historic Baxter Hotel in Bozeman...
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10, 20...
The 'Goldilocks' Case For Baxter International
Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health ...
Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President and Chief Investor Relations Officer Brent Sh...
Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps
On Thursday, Baxter International Inc. BAX reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.
Baxter tops quarterly estimates on strong demand for medical devices
Medical products maker Baxter International on Thursday beat Wall Street estimates for first-quarter revenue and profit, helped by the robust demand for its intravenous (IV) solutions and patient-moni...
Baxter Reports First-Quarter 2025 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025. “Our solid performance in the first quarter of 20...
Baxter to Present at Bank of America Securities 2025 Health Care Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Jo...
Goldman's John Marshall provides stock opportunities ahead of earning season
John Marshall, Goldman Sachs head of derivatives research, joins 'Money Movers' to discuss the current market environment, individual companies Goldman looked at, and much more.
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature st...